BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26057149)

  • 1. Epstein-Barr virus latent membrane protein 2A mediated activation of Sonic Hedgehog pathway induces HLA class Ia downregulation in gastric cancer cells.
    Deb Pal A; Banerjee S
    Virology; 2015 Oct; 484():22-32. PubMed ID: 26057149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of HLA-ABC expression through promoter hypermethylation and downmodulation of MIC-A/B surface expression in LMP2A-positive epithelial carcinoma cell lines.
    Singh S; Banerjee S
    Sci Rep; 2020 Mar; 10(1):5415. PubMed ID: 32214110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of locus-specific human lymphocyte antigen class I expression in Epstein-Barr virus-associated gastric cancer: implication for viral-induced immune evasion.
    Dutta N; Gupta A; Mazumder DN; Banerjee S
    Cancer; 2006 Apr; 106(8):1685-93. PubMed ID: 16541432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: implications for cytotoxic T-lymphocyte control of EBV-associated malignancies.
    Khanna R; Burrows SR; Moss DJ; Silins SL
    J Virol; 1996 Aug; 70(8):5357-62. PubMed ID: 8764046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct Roles of Extracellular Domains in the Epstein-Barr Virus-Encoded BILF1 Receptor for Signaling and Major Histocompatibility Complex Class I Downregulation.
    Fares S; Spiess K; Olesen ETB; Zuo J; Jackson S; Kledal TN; Wills MR; Rosenkilde MM
    mBio; 2019 Jan; 10(1):. PubMed ID: 30647152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global Proteomic Changes Induced by the Epstein-Barr Virus Oncoproteins Latent Membrane Protein 1 and 2A.
    DeKroon RM; Gunawardena HP; Edwards R; Raab-Traub N
    mBio; 2018 Jun; 9(3):. PubMed ID: 29921667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) enhances IL-10 production through the activation of Bruton's tyrosine kinase and STAT3.
    Incrocci R; Barse L; Stone A; Vagvala S; Montesano M; Subramaniam V; Swanson-Mungerson M
    Virology; 2017 Jan; 500():96-102. PubMed ID: 27792904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus latent membrane protein 2 induces autophagy to promote abnormal acinus formation.
    Fotheringham JA; Raab-Traub N
    J Virol; 2015 Jul; 89(13):6940-4. PubMed ID: 25878108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus.
    Steinbrück L; Gustems M; Medele S; Schulz TF; Lutter D; Hammerschmidt W
    J Virol; 2015 Jul; 89(14):7248-61. PubMed ID: 25948739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Epstein-Barr virus-encoded latent membrane protein 2A on virus-induced immortalization and virus activation.
    Konishi K; Maruo S; Kato H; Takada K
    J Gen Virol; 2001 Jun; 82(Pt 6):1451-1456. PubMed ID: 11369890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.
    Wasil LR; Wei L; Chang C; Lan L; Shair KH
    J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus latent membrane 2A (LMP2A) down-regulates telomerase reverse transcriptase (hTERT) in epithelial cell lines.
    Chen F; Liu C; Lindvall C; Xu D; Ernberg I
    Int J Cancer; 2005 Jan; 113(2):284-9. PubMed ID: 15389515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP.
    Murray RJ; Wang D; Young LS; Wang F; Rowe M; Kieff E; Rickinson AB
    J Virol; 1988 Oct; 62(10):3747-55. PubMed ID: 2843672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma.
    Hino R; Uozaki H; Murakami N; Ushiku T; Shinozaki A; Ishikawa S; Morikawa T; Nakaya T; Sakatani T; Takada K; Fukayama M
    Cancer Res; 2009 Apr; 69(7):2766-74. PubMed ID: 19339266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus latent membrane protein 2A contributes to anoikis resistance through ERK activation.
    Iwakiri D; Minamitani T; Samanta M
    J Virol; 2013 Jul; 87(14):8227-34. PubMed ID: 23698301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide identification of Epstein-Barr virus-driven promoter methylation profiles of human genes in gastric cancer cells.
    Zhao J; Liang Q; Cheung KF; Kang W; Lung RW; Tong JH; To KF; Sung JJ; Yu J
    Cancer; 2013 Jan; 119(2):304-12. PubMed ID: 22833454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras/PI3-K/Akt Pathway.
    Fukuda M; Longnecker R
    J Virol; 2007 Sep; 81(17):9299-306. PubMed ID: 17582000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus (EBV) LMP2A alters normal transcriptional regulation following B-cell receptor activation.
    Portis T; Longnecker R
    Virology; 2004 Jan; 318(2):524-33. PubMed ID: 14972521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma.
    Jones K; Wockner L; Brennan RM; Keane C; Chattopadhyay PK; Roederer M; Price DA; Cole DK; Hassan B; Beck K; Gottlieb D; Ritchie DS; Seymour JF; Vari F; Crooks P; Burrows SR; Gandhi MK
    Clin Exp Immunol; 2016 Feb; 183(2):206-20. PubMed ID: 26422112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.